Eradication of Minimal Residual Disease in B-Cell Chronic Lymphocytic Leukemia After Alemtuzumab Therapy Is Associated With Prolonged Survival von MORETON, Paul, KENNEDY, Ben, HILLMEN, Peter, LUCAS, Guy, LEACH, Michael, RASSAM, Saad M. B, HAYNES, Andrew, TIGHE, Jane, OSCIER, David, FEGAN, Christopher, RAWSTRON, Andy

Volltext

An examination of the major-accident record for explosives manufacturing and storage in the UK von Merrifield, R, Moreton, P.A

Volltext

Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administration von Hale, Geoff, Rebello, Peppy, Brettman, Lee R., Fegan, Chris, Kennedy, Ben, Kimby, Eva, Leach, Mike, Lundin, Jeanette, Mellstedt, Håkan, Moreton, Paul, Rawstron, Andy C., Waldmann, Herman, Osterborg, Anders, Hillmen, Peter

Volltext

The development of targeted chemotherapy for CNS lymphoma-a pilot study of the IDARAM regimen von MORETON, P, MORGAN, G. J, PARAPIA, L. A, WILLIAMS, A. T, CHILD, J. A, GILSON, D, SMITH, G. M, MCVERRY, B. A, DAVIES, J. M, MACKIE, M. J, BOLAM, S, JALIHAL, S. S, HOWARD, M. R

Volltext

Phase II study of subcutaneous alemtuzumab without dose escalation in patients with advanced‐stage, relapsed chronic lymphocytic leukaemia von Karlsson, Claes, Lundin, Jeanette, Kimby, Eva, Kennedy, Ben, Moreton, Paul, Hillmen, Peter, Österborg, Anders

Volltext

Optimising alemtuzumab therapy for refractory B cell chronic lymphocytic leukaemia (CLL) von Hillmen, P., Moreton, P.

Volltext

Optimising alemtuzumab therapy for refractory B cell chronic lymphocytic leukaemia (CLL) von Hillmen, P., Moreton, P.

Volltext

Early prediction of outcome and response to alemtuzumab therapy in chronic lymphocytic leukemia von Rawstron, Andy C., Kennedy, Ben, Moreton, Paul, Dickinson, Anita J., Cullen, Matthew J., Richards, Stephen J., Jack, Andrew S., Hillmen, Peter

Volltext

Simplified curve and surface interrogation via mathematical packages and graphics libraries and hardware von Moreton, Henry P

Volltext

Total mercury, methyl mercury and sulphide levels in British estuarine sediments—III von Craig, P.J., Moreton, P.A.

Volltext

The proliferating cells in CLL have a unique immunophenotype von Moreton, P, Hillmen, P, Jack, A S

Volltext

The role of sulphide in the formation of dimethyl mercury in river and estuary sediments von Craig, P.J., Moreton, P.A.

Volltext

The correlation between the eradication of minimal residual disease (MRD) following alemtuzumab for CLL and overall survival von Moreton, P., Kennedy, B., Rawstron, A., Hillmen, P.

Volltext

The correlation between the eradication of minimal residual disease (MRD) following alemtuzumab for CLL and overall survival von Moreton, P., Kennedy, B., Rawstron, A., Hillmen, P.

Volltext

Total mercury, methyl mercury and sulphide in river carron sediments von Craig, P.J., Moreton, P.A.

Volltext

Évaluation de la mise en place d’une procédure d’optimisation de la stratégie transfusionnelle d’urgence au déchocage au CHU de Saint-Étienne von Tremblay, A., Revoirard, O., Ezingeard, E., Oriol, P., Benamara, H., Moreton, P., Gergelé, L.

Volltext

Produits sanguins rendus non transfusés : analyse des causes sur huit mois au CHU de Saint-Étienne von Lachand, R., Oriol, P., Benamara, H., Redon, C., Moreton, P., Pozzetto, B.

Volltext

Cytomegalovirus (CMV) infection in patients treated with alemtuzumab and other non-transplant therapies - a manageable complication with early detection by preemptive screening von Sah, A, Moreton, P, Klapper, P E, Hale, A D, Hillmen, P

Volltext

Prise en charge des thrombopénies néonatales avec suspicion d’incompatibilité fœto-maternelle von Benamara, A., Varlet, M.N., Absi, L., Moreton, P., Boussoulade, F., Chavarin, P., Flourie, F., Duboeuf, S., Garraud, O.

Volltext

Valuations for mortgage purposes - The background for a valuation survey von Moreton, P

Volltext